REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Perusahaan Dagang Dan Industrie Itrasal (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Perusahaan Dagang Dan Industrie Itrasal Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Perusahaan Dagang Dan Industrie Itrasal is a company in Indonesia, with a head office in Semarang. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on September 17, 1958. There was a net sales revenue increase of 17.89% reported in PT Perusahaan Dagang Dan Industrie Itrasal’s latest financial highlights for 2022. Its’ total assets recorded a growth of 16.08%.

Headquarters
Kota Semarang Ngemplak Simongan Semarang Barat Jawa Tengah
Semarang; Central Java; Postal Code: 50148

Contact Details: Purchase the PT Perusahaan Dagang Dan Industrie Itrasal report to view the information.

Basic Information
Outstanding Shares:
Purchase the PT Perusahaan Dagang Dan Industrie Itrasal report to view the information.
Registered Capital:
Purchase the PT Perusahaan Dagang Dan Industrie Itrasal report to view the information.
Incorporation Date:
September 17, 1958
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Perusahaan Dagang Dan Industrie Itrasal report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.89%
Total operating revenue
17.89%
Total assets
16.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?